STOK
Stoke Therapeutics Inc
24.80$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.9% | 94.3% | 94.2% | 96.5% | 86.5% | 85.7% | 92.3% | 70.2% | 75.6% | 73.1% | 82.7% | 81.9% | |
| 79.2% | 83.8% | 87.0% | 62.9% | 51.1% | 47.1% | 67.5% | 26.4% | 23.1% | 20.1% | 35.1% | 27.9% | |
| 89.5% | 88.2% | 87.0% | 91.6% | 81.5% | 79.9% | 87.8% | 64.4% | 68.9% | 68.0% | 77.5% | 74.3% | |
| 0.0% | 0.0% | 0.0% | 0.1% | 0.2% | 0.3% | 0.1% | 0.4% | 3.0% | 1.9% | 1.4% | 2.2% | |
| 4.6% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| 3.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 27.9% | 30.1% | 31.6% | 21.1% | 20.9% | 15.7% | 14.0% | 12.9% | 14.5% | 15.8% | 10.9% | 12.3% | |
| 10.5% | 13.5% | 17.3% | 14.5% | 17.0% | 14.8% | 11.0% | 10.1% | 11.6% | 13.8% | 9.2% | 10.6% | |
| 1.0% | 0.9% | 1.1% | 0.7% | 0.8% | 0.9% | 0.6% | 0.6% | 0.8% | 0.7% | 0.5% | 0.5% | |
| 1.3% | 0.7% | 1.0% | 1.3% | 0.8% | 0.9% | 0.5% | 1.1% | 1.6% | 1.2% | 1.5% | 1.2% | |
| 72.1% | 69.9% | 68.4% | 78.9% | 79.1% | 84.3% | 86.0% | 87.1% | 85.5% | 84.2% | 89.1% | 87.7% | |
| -156.3% | -176.0% | -208.7% | -147.5% | -163.8% | -180.7% | -92.9% | -104.4% | -122.1% | -118.9% | -123.6% | -154.7% | |
| 18.5% | 19.7% | 22.5% | 18.1% | 19.2% | 21.0% | 14.6% | 15.2% | 16.3% | 14.0% | 14.2% | 16.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.